BioSig Technologies, Inc.
BSGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.84 | -0.01 | -0.05 | 1.36 |
| FCF Yield | -0.26% | -0.06% | -1.32% | -0.23% |
| EV / EBITDA | -128.53 | -99.73 | -29.06 | -90.52 |
| Quality | ||||
| ROIC | -118.58% | 590.46% | -106.61% | 89.62% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.32 | 0.06 | 0.40 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | -54.82% | -63.84% | -54.88% | -48.09% |
| Free Cash Flow Growth | -293.04% | -14.62% | -135.23% | 68.17% |
| Safety | ||||
| Net Debt / EBITDA | 0.74 | 0.14 | 1.32 | 0.02 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -394.33 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 754.62 |